Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

REGN5093-M114

REGN5093-M114 is a bispecific antibody-drug conjugate (ADC) that targets two epitopes of the MET receptor tyrosine kinase inhibits the proliferation of NSCLC cells, exhibits antitumor efficacy in mouse models. REGN5093-M114 is composed of the human monoclonal anti-MET antibody Davutamig and the tubulin-inhibiting linker-payload (HY-148528).

Product Specifications

UNSPSC

12352203

Target

Antibody-Drug Conjugates (ADCs) ; c-Met/HGFR; Microtubule/Tubulin

Related Pathways

Antibody-drug Conjugate/ADC Related; Cell Cycle/DNA Damage; Cytoskeleton; Protein Tyrosine Kinase/RTK

Field of Research

Cancer

Smiles

[REGN5093-M114]

References & Citations

[1]Dardare J, et al., REGN5093-M114: can an antibody-drug conjugate overcome the challenge of resistance to epidermal growth factor receptor and mesenchymal epithelial transition tyrosine kinase inhibitors in non-small cell lung cancer? Transl Lung Cancer Res. 2024 Aug 31;13 (8) :2082-2086.

Shipping Conditions

Room temperature

Scientific Category

ADC Related

Clinical Information

Phase 2

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

pCR4-TOPO-GABRR1 Plasmid
PVT21502 2 µg

pCR4-TOPO-GABRR1 Plasmid

Sign In for Pricing
View Details
Hsa-miR-6726-3p antagomir
HY-RI02009A-01 5 nmol

Hsa-miR-6726-3p antagomir

Sign In for Pricing
View Details
Hsa-miR-6726-3p antagomir
HY-RI02009A-02 20 nmol

Hsa-miR-6726-3p antagomir

Sign In for Pricing
View Details
RANBP3 Rabbit Polyclonal Antibody (Biotin)
orb2099938 100 µL

RANBP3 Rabbit Polyclonal Antibody (Biotin)

Sign In for Pricing
View Details
MAP2K3 Antibody (Phospho-Thr222) : FITC (OAAF00457-FITC)
OAAF00457-100UG-FITC 100 µg

MAP2K3 Antibody (Phospho-Thr222) : FITC (OAAF00457-FITC)

Sign In for Pricing
View Details
(-) -Ageloxime D
GL3628-1mg 1 mg

(-) -Ageloxime D

Sign In for Pricing
View Details